MedPath

Evaluation of SureCore Plus Biopsy System

Not Applicable
Not yet recruiting
Conditions
BPH
Interventions
Device: Evaluation of two biopsy systems
Registration Number
NCT06550960
Lead Sponsor
Uro-1 Medical
Brief Summary

This is a post-market study of a cleared biopsy system. The quality of tissue cores varies with standard of care biopsy needles. The SureCore Plus biopsy system is being evaluated as to quality and volume of tissue from prostate biopsy as compared to standard of care biopsy needles.

Detailed Description

Biopsy sampling of the prostate using TRUS or TPPB guidance is the current SoC approach for diagnosis of prostate cancer (CaP). Over the past decades the number of samples required and considered adequate has risen from 6 to 12-18 and sometimes as many as 30. Many practices routinely sample up to 20 cores of tissue. The SureCore Plus biopsy system is being to sample, obtain and retrieve prostate biopsy specimens in men undergoing scheduled diagnostic prostate biopsy and compare it with an standard of care (SoC) biopsy instrument and SoC method of specimen retrieval.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
Male
Target Recruitment
30
Inclusion Criteria
  • Patient has BPH requiring a prostate biopsy
  • Able and willing to provide consent
Read More
Exclusion Criteria
  • Active infection
  • Subject participating in an other device study of the prostate
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
SureCore Plus biopsy needleEvaluation of two biopsy systemsProstate biopsy of subject with BPH with a SureCore biopsy needle
Standard of Care biopsy needleEvaluation of two biopsy systemsProstate biopsy of subject with BPH with a standard of care (SOC) biopsy needle
Primary Outcome Measures
NameTimeMethod
Procedure successDuring the procedure

\> 3 mm/cc of tissue collected in each biopsy

Quality of biopsy tissueDuring the procedure

Ranking by pathologist on scale of 0=unable to read to 5=all tissue complete for reading. The higher scores mean a better outcome.

Secondary Outcome Measures
NameTimeMethod
Performance of the study deviceDuring the procedure

Ranking by MD using scale of 1=difficult to use to 5=outperformed SOC needles. The higher scores equate to better outcome.

© Copyright 2025. All Rights Reserved by MedPath